Molecular signature of late-stage human ALS revealed by expression profiling of postmortem spinal cord gray matter

Abstract excerpt

Little is known about global gene expression patterns in the human neurodegenerative disease amyotrophic lateral sclerosis (ALS). To address this, we used high-density oligonucleotide microarray technology to compare expression levels of approximately 6,800 genes in postmortem spinal cord gray matter obtained from individuals with ALS as well as normal individuals. Using Fisher discriminant analysis (FDA) and...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Amyotrophic Lateral Sclerosis Research
• Share to biodegradable polymer synthesis and properties
• Share to Neurogenetic and Muscular Disorders Research